Skip to main content
Clinical Trials/CTRI/2023/03/050710
CTRI/2023/03/050710
Not yet recruiting
未知

Assessment and comparison of short term efficacy of adjunctive continuous theta burst stimulation over supplementary motor area in functional neurological symptom disorder (seizure type): a randomized sham-controlled trial

Sri Guru Ram Rai Institute Of Medical And Health Sciences0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sri Guru Ram Rai Institute Of Medical And Health Sciences
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Sri Guru Ram Rai Institute Of Medical And Health Sciences

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient with a diagnosis of FND\-S, based on the diagnostic criteria of diagnostic and statistical manual of mental disorder, fifth edition (DSM 5\) or international classification of disease (ICD 11\) and confirmed by video EEG monitoring or video monitoring.
  • 2\.Patient aged between 15\-59 years.
  • 3\.Patient with diagnosis of PNES with monthly frequency of \>3 seizures (for at least a month).
  • 4\.Patient giving written consent to participate in protocol. For an adolescent, sample consent will be taken from the guardian.
  • 5\.Normotensive patients.
  • 6\.Patients not receiving any psychotherapy in last one month.

Exclusion Criteria

  • 1\.Patient is uncooperative for the procedure.
  • 2\.Patient with history of previous or current epilepsy
  • 3\.Patients receiving ECT in past 6 months.
  • 4\.Patient with severe mental disorders (SMD).
  • 5\.Patient with implanted metallic devices.
  • 6\.Any co morbid substance use disorders except nicotine and caffeine (as per DSM 5\).
  • 7\.Patient with other neurovascular comorbidities (tumor,cerebrovascular events (CVE), cranio\-encephalic trauma.
  • 8\.Significant unstable medical condition like uncontrolled hypertension, complicated diabetes mellitus or any organ failure.

Outcomes

Primary Outcomes

Not specified

Similar Trials